• Adoptarea Cartei Europene a cercetătorilor și a Codului de conduită pentru recrutarea cercetătorilor

În data de 28.08.2024, Institutul de Biologie și Patologie Celulară „Nicolae Simionescu“ a primit Diploma de Excelență pentru Resurse Umane în Cercetare de la Comisia Europeană.

Detalii aici: https://www.icbp.ro/static/en/en-careers/otmr_strategy_hrs4r.html

• Laura Toma, Mariana Deleanu, Gabriela M. Sanda, Teodora Barbălată, Loredan S. Niculescu, Anca V. Sima, Camelia S. Stancu. Bioactive Compounds Formulated in Phytosomes Administered as Complementary Therapy for Metabolic Disorders. International Journal of Molecular Sciences 25(8): 4162, 2024. doi: 10.3390/ijms25084162 (Q1-ranked).

International Conference Vascular Medicine and Atherosclerosis Congress 2026

Köln/Cologne, Germany, 5-7 February 2026

• Oral communication: Teodora Barbălată, Gabriela M. Sanda, Laura Toma, Jessica I.C. Hărătau (Ciobanu), Elena V. Fuior, Mădălina I. Fenyo, Loredan S. Niculescu, Shlomo Sasson, Anca V. Sima, Camelia S. Stancu. Hepatic CRISPR/dCas9-mediated overexpression of apolipoprotein A1 and paraoxonase 1 reduces the atherosclerotic burden in apoE deficient mice.
• Poster communication: Jessica I. C. Hărătău (Ciobanu), Loredan S. Niculescu, Elena V. Fuior, Anca V. Sima, Shlomo Sasson, Camelia S. Stancu, Laura Toma. CRISPR/dCas9 long-term transcriptional activation of apolipoprotein A1 and paraoxonase 1 in hepatocytes to ameliorate endothelial cell dysfunction.

Al 46-lea Simpozion Științific Anual IBPC-NS „Progrese în cercetarea translațională a sistemului cardiovascular pentru sănătatea inimii”

București, 17-18 decembrie 2025

• Comunicare cu Poster: Gabriela M. Sanda, Laura Toma, Jessica Ciobanu, Teodora Barbălată, Elena V. Fuior, Mădălina I. Fenyo, Loredan S. Niculescu, Anca V. Sima, Camelia S. Stancu. Transcriptional activation of endogenous glutathione peroxidases by CRISPR/dCas9 technology to improve the antioxidant protection of enterocytes in vitro and in vivo.

Conferința Internațională: 42nd Annual Scientific Session of the Romanian Society for Cell Biology

București, 20-21 noiembrie 2025

• Oral presentation - Young Scientists Session: Laura Toma#, Teodora Barbălată#, Jessica I.C. Ciobanu, Gabriela M. Sanda, Elena V. Fuior, Mădălina I. Fenyo, Loredan S. Niculescu, Anca V. Sima, Camelia S. Stancu. Overexpression of endogenous apolipoprotein A-I and paraoxonase 1 genes in the liver of apoe-/- mice by CRISPR/dCas9; an approach to impede atherosclerosis progression.
• Short Communications Session (e-Poster): Laura M. Dăian, Andrei M. Văcaru, Elena M. Lambă, Oana A.-M. Mardare, Ana-Maria Văcaru. Preliminary Dynamics of β-Cell Adjustment to Reduced Mass and Diet-Related Stress
• Short Communications Session (e-Posters): Elena Mirela Lambă, Oana-Ana-Maria Mardare, Laura Maria Daian, Andrei Mircea Văcaru, Ana-Maria Văcaru. Sweet Habits: Shaping Pancreatic β-cell Adaptation

Conferința Internațională: Molecular Biology - Current Aspects and Prospects

Cluj-Napoca, 4-7 noiembrie 2025

• Oral presentation: Jessica I.C. Ciobanu, Teodora Barbalata, Laura Toma, Elena V. Fuior, Madalina I. Fenyo, Anca V. Sima, Camelia S. Stancu.. CRISPR/dCas9 Long-Term Transcriptional Activation of Hepatic Alipoprotein A-I And Paraoxonase 1 to Improve HDL Function.

61st Annual Meeting of European Association for the Study of Diabetes (EASD)

Viena, Austria, 15-19 September 2025

• Short oral presentation: Laura Toma, Teodora Barbălată, Jessica I.C. Ciobanu, Gabriela M. Sanda, Elena V. Fuior, Mădălina I. Fenyo, Loredan S. Niculescu, Anca V. Sima, Camelia S. Stancu. Transcriptional activation of endogenous paraoxonase 2 by CRISPR/dCas9 technology to improve the function of hepatocytes under pro-diabetic conditions; an in vitro and in vivo strategy.

Congresul Federation of European Biochemical Societies (FEBS) 2025

Istanbul, Turkey, 5-9 July 2025

• Poster communication: Teodora Barbălată, Oriana E. Moraru, Gabriela M. Sanda, Laura Toma, Camelia S. Stancu, Anca V. Sima, Loredan S. Niculescu. Circulating non-coding RNAs as promising biomarkers for atherosclerosis.
• Poster communication: Gabriela M. Sanda, Laura Toma, Jessica I.C. Ciobanu, Teodora Barbalata, Elena V. Fuior, Madalina I. Fenyo , Loredan S. Niculescu, Anca V. Sima, Camelia S. Stancu. Transcriptional activation of endogenous glutathione peroxidases by CRISPR/dCas9 technology to improve the antioxidant protection of enterocytes in vitro and in vivo.

Atherosclerosis - Gordon Research Conference "Genetics, Pathophysiology, and Translation"

Castelldefels, Spania, 22 - 27 June 2025

• Poster communication: Laura Toma, Teodora Barbălată, Jessica I.C. Ciobanu, Gabriela M. Sanda, Elena V. Fuior, Madalina I. Fenyo, Loredan S. Niculescu, Anca V. Sima, Camelia S. Stancu. Transcriptional activation of endogenous apolipoprotein A-I and paraoxonase 1 by CRISPR/dCas9 technology to improve the function of high-density lipoproteins.

International Conference The 41st Annual Scientific Session of the Romanian Society for Cell Biology (RSCB)

Târgu Mureș, România, 11-13 December 2024

• Oral communication in PhD students Session: Jessica I.C. Ciobanu, Laura Toma, Elena V. Fuior, Gabriela M. Sanda, Anca V. Sima, Camelia S. Stancu. CRISPR/dCas9 long-term transcriptional activation of hepatic key proteins to improve HDL function.
• Poster communication: Teodora Barbălată, Orina Moraru, Gabriela M. Sanda, Laura Toma, Camelia S. Stancu, Anca V. Sima, Loredan S. Niculescu. Non-coding RNAs as novel biomarkers in atherosclerosis.

The „XXXVII National Chemistry Conference CNCHIM 2024”, Târgoviște, Romania, 25-27 September 2024

• Poster communication: Mariana Deleanu, Laura Toma, Gabriela Sanda, Anca V. Sima, Justinian Tomescu, Georgeta Alexandru, Camelia S. Stancu. Preparation and characterization of hawthorn berries and grapes skin extracts; antioxidant and anti-inflammatory effects in endothelial cells.